Published in FEBS Open Bio on June 06, 2014
Gene expression in the liver of female, but not male mice treated with rapamycin resembles changes observed under dietary restriction. Springerplus (2015) 0.76
Dopamine-prolactin pathway potentially contributes to the schizophrenia and type 2 diabetes comorbidity. Transl Psychiatry (2016) 0.75
T2D and Depression Risk Gene Proteasome Modulator 9 is Linked to Insomnia. Sci Rep (2015) 0.75
A simple method for displaying the hydropathic character of a protein. J Mol Biol (1982) 150.65
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol (1993) 64.61
The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction. Physiol Rev (2002) 16.10
A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations. J Comput Chem (2003) 15.88
HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J Am Chem Soc (2003) 11.65
Hydrophobicity of amino acid residues in globular proteins. Science (1985) 5.64
Two binding orientations for peptides to the Src SH3 domain: development of a general model for SH3-ligand interactions. Science (1994) 4.57
Affinities of amino acid side chains for solvent water. Biochemistry (1981) 4.46
Diversity of degradation signals in the ubiquitin-proteasome system. Nat Rev Mol Cell Biol (2008) 4.42
Ubiquitin and the control of protein fate in the secretory and endocytic pathways. Annu Rev Cell Dev Biol (1998) 4.15
Surface and inside volumes in globular proteins. Nature (1979) 3.91
A specificity map for the PDZ domain family. PLoS Biol (2008) 3.16
Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc Natl Acad Sci U S A (1994) 3.09
ER-associated degradation in protein quality control and cellular regulation. Curr Opin Cell Biol (2002) 2.97
Soluble gp130 is the natural inhibitor of soluble interleukin-6 receptor transsignaling responses. Eur J Biochem (2001) 2.30
Role of the proteasome in membrane extraction of a short-lived ER-transmembrane protein. EMBO J (1998) 2.23
PDZ domains and their binding partners: structure, specificity, and modification. Cell Commun Signal (2010) 2.07
The ubiquitin-proteasome system and endocytosis. J Cell Sci (1999) 1.87
Predicting PDZ domain-peptide interactions from primary sequences. Nat Biotechnol (2008) 1.86
Phage display for engineering and analyzing protein interaction interfaces. Curr Opin Struct Biol (2007) 1.81
Interaction of an apolipoprotein (apoLP-alanine) with phosphatidylcholine. Biochemistry (1973) 1.81
Opposing functions of TFII-I spliced isoforms in growth factor-induced gene expression. Mol Cell (2006) 1.81
The pathway of US11-dependent degradation of MHC class I heavy chains involves a ubiquitin-conjugated intermediate. J Cell Biol (1999) 1.74
Protein-protein docking with a reduced protein model accounting for side-chain flexibility. Protein Sci (2003) 1.73
Cleaning up in the endoplasmic reticulum: ubiquitin in charge. Nat Struct Mol Biol (2014) 1.66
Inhibition of Wnt signaling by Dishevelled PDZ peptides. Nat Chem Biol (2009) 1.65
Insulin protects islets from apoptosis via Pdx1 and specific changes in the human islet proteome. Proc Natl Acad Sci U S A (2006) 1.63
Proteasome inhibitors block a late step in lysosomal transport of selected membrane but not soluble proteins. Mol Biol Cell (2001) 1.47
Mechanisms of soluble cytokine receptor generation. J Immunol (2004) 1.44
Energetics of target peptide binding by calmodulin reveals different modes of binding. J Biol Chem (2001) 1.44
Analysis of PDZ domain-ligand interactions using carboxyl-terminal phage display. J Biol Chem (2000) 1.44
Uncovering quantitative protein interaction networks for mouse PDZ domains using protein microarrays. J Am Chem Soc (2006) 1.40
Bridge-1, a novel PDZ-domain coactivator of E2A-mediated regulation of insulin gene transcription. Mol Cell Biol (1999) 1.38
Mechanism of polypeptide translocation into the endoplasmic reticulum. J Biol Chem (1996) 1.28
Potential roles for ubiquitin and the proteasome during ribosome biogenesis. Mol Cell Biol (2006) 1.25
Proteasome inhibition induces reversible impairments in protein synthesis. FASEB J (2006) 1.20
Ribosomal protein S14 unties the MDM2-p53 loop upon ribosomal stress. Oncogene (2012) 1.19
Exploring protein-protein interactions with phage display. Chembiochem (2003) 1.17
Assembling stable hair cell tip link complex via multidentate interactions between harmonin and cadherin 23. Proc Natl Acad Sci U S A (2009) 1.16
Molecular shredders: how proteasomes fulfill their role. Curr Opin Struct Biol (2003) 1.04
One from column A and two from column B: the benefits of phage display in molecular-recognition studies. Curr Opin Chem Biol (2002) 1.03
Inhibition of protein aggregation: supramolecular assemblies of arginine hold the key. PLoS One (2007) 1.02
Nonsense-mediated mRNA decay: insights into mechanism from the cellular abundance of human Upf1, Upf2, Upf3, and Upf3X proteins. Cold Spring Harb Symp Quant Biol (2001) 1.02
Loss of Rpt5 protein interactions with the core particle and Nas2 protein causes the formation of faulty proteasomes that are inhibited by Ecm29 protein. J Biol Chem (2011) 1.01
Structural studies on the forward and reverse binding modes of peptides to the chaperone DnaK. J Mol Biol (2013) 0.94
MG132 proteasome inhibitor modulates proinflammatory cytokines production and expression of their receptors in U937 cells: involvement of nuclear factor-kappaB and activator protein-1. Immunology (2008) 0.94
The role of flexibility and conformational selection in the binding promiscuity of PDZ domains. PLoS Comput Biol (2012) 0.92
Interaction between hnRNPA1 and IkappaBalpha is required for maximal activation of NF-kappaB-dependent transcription. Mol Cell Biol (2001) 0.92
Discovery of multiple interacting partners of gankyrin, a proteasomal chaperone and an oncoprotein--evidence for a common hot spot site at the interface and its functional relevance. Proteins (2014) 0.91
Proteasomal degradation of Sfp1 contributes to the repression of ribosome biogenesis during starvation and is mediated by the proteasome activator Blm10. Mol Biol Cell (2011) 0.90
Proteasome inhibition induces TNFR1 shedding from human airway epithelial (NCI-H292) cells. Am J Physiol Lung Cell Mol Physiol (2005) 0.88
T7 phage display as a method of peptide ligand discovery for PDZ domain proteins. Biopolymers (2009) 0.87
Antigen presentation by MART-1 adenovirus-transduced interleukin-10-polarized human monocyte-derived dendritic cells. Immunology (2004) 0.85
Proteasome inhibition activates the transport and the ectodomain shedding of TNF-alpha receptors in human endothelial cells. J Cell Sci (2005) 0.85
Arginine improves protein elution in hydrophobic interaction chromatography. The cases of human interleukin-6 and activin-A. J Chromatogr A (2007) 0.85
Go outside and see the proteasome. Protein degradation. Curr Biol (1996) 0.83
Unusual binding interactions in PDZ domain crystal structures help explain binding mechanisms. Protein Sci (2010) 0.83
Non-denaturing solubilization of inclusion bodies. Curr Pharm Biotechnol (2010) 0.83
Interactions with p300 enhance transcriptional activation by the PDZ-domain coactivator Bridge-1. J Endocrinol (2005) 0.83
Direct ubiquitin independent recognition and degradation of a folded protein by the eukaryotic proteasomes-origin of intrinsic degradation signals. PLoS One (2012) 0.83
Two isoforms of Sister-Of-Mammalian Grainyhead have opposing functions in endothelial cells and in vivo. Arterioscler Thromb Vasc Biol (2013) 0.83
CXCR4-mediated suppressor of cytokine signaling up-regulation inactivates growth hormone function. J Biol Chem (2004) 0.82
Conformational change upon ligand binding and dynamics of the PDZ domain from leukemia-associated Rho guanine nucleotide exchange factor. Protein Sci (2008) 0.81
Protective signaling pathways of activated protein C in endothelial cells. Arterioscler Thromb Vasc Biol (2008) 0.80
Genome-wide analyses of carboxyl-terminal sequences. Mol Cell Proteomics (2003) 0.79
Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO. Immunol Lett (2012) 0.76